| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4383eff7d424f33a5252d6973036a564 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83bb2f72dd70f4620b21cf7642a4854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_343316cc6bb9238450d65215e0a0a1d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c83bfd17408ce8153f691b3f0b9d60b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37a6e46913dbd688d32d8f26477efb8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca476887c00c4650c3aa14cd1a66384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d2d2a0796c58b47576e609ebbe40f79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fddbe9e0887c2d3abb9d598261c9bd9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e435e14c8b76471576855e05763313e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0fa578db3e615432d646b309e56fe04 |
| publicationDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2009231841-B2 |
| titleOfInvention |
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling |
| abstract |
Derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met, pharmaceutical compositions containing derivatives and analogs of c-Met inhibitors are provided. Methods of making derivatives and analogs of c-Met inhibitors and methods of use thereof are provided. |
| priorityDate |
2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |